Alberto Abbruzzese

Familial papillary thyroid microcarcinoma: a new clinical entity

Giovanni Lupoli, Giovanni Vitale, Michele Caraglia et al. · The Lancet · 1999 · 198 citations

Medicine, Oncology, Pathology +14

Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance

Raffaele Addeo, Michele Caraglia, Sergio Bellini et al. · Journal of Clinical Oncology · 2009 · 190 citations

Medicine, Oncology, Pharmacology +13

Critical role of both p27^KIP1and p21^CIP1/WAF1 in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells

Elena Di Gennaro, Marcella Barbarino, Francesca Bruzzese et al. · Journal of Cellular Physiology · 2003 · 131 citations

Medicine, Oncology, Pharmacology +17

Desferioxamine increases iron depletion and apoptosis induced by ara‐C of human myeloid leukaemic cells

A. Leardi, Michele Caraglia, Carmine Selleri et al. · British Journal of Haematology · 1998 · 121 citations · Full text

Medicine, Hematology, Pharmacology +11

Electromagnetic fields at mobile phone frequency induce apoptosis and inactivation of the multi‐chaperone complex in human epidermoid cancer cells

Michele Caraglia, Monica Marra, Fabrizio Mancinelli et al. · Journal of Cellular Physiology · 2005 · 113 citations

Life Sciences, Cell Biology, Oncology +17